 LA JOLLA, Calif., March 09, 2021 GLOBE NEWSWIRE -- Artelo Biosciences, Inc. NASDAQ: ARTL , a clinical stage biopharmaceutical company focused on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system, today announced the appointment of Tamara A. Seymour, CPA, to the Companys board of directors. 